Skip to main content
Atrás
Watch Compare

ARTELO BIOSCIENCES, INC.

Calidad de datos: 83%
ARTL
Nasdaq Manufacturing Chemicals
$5.95
▼ $0.56 (-8.60%)
Cap. Mercado: 5.32 M
Precio
$6.51
Cap. Mercado
5.32 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -8.52 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio0.38
Interest Coverage-58.78

Valoración

PE (TTM)
-0.41
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -0.4 -1.5
P/B — 1.6
ROE % — -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

No hay cobertura de analistas disponible

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2027 -$5.28
-$5.28 – -$5.28
 0.0 1
FY2026 -$9.84
-$9.84 – -$9.84
 0.0 1

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$4.71 -$0.12 +97.5%
Q32025 N/A -$11.91 —
Q22025 -$12.57 -$16.83 -33.9%
Q12025 -$2.34 -$12.96 -453.9%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -12.88 M
ROE N/A ROA -298.68%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -8.52 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.38
Interest Coverage -58.78 Asset Turnover N/A
Working Capital -3.03 M Tangible Book Value -2.67 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.41 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -160.17%
Market Cap 5.32 M Enterprise Value 5.32 M
Per Share
EPS (Diluted TTM) -12.52 Revenue / Share N/A
FCF / Share -10.43 OCF / Share -10.43
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 66.15%
SBC-Adj. FCF -9.50 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -12.88 M -9.83 M -9.29 M -10.08 M -7.44 M
EPS (Diluted) -12.52 -3.05 — — —
Gross Profit — — — — —
Operating Income -11.40 M -10.11 M -9.93 M -10.29 M -7.44 M
EBITDA — — — — —
R&D Expenses 5.42 M 5.99 M 5.70 M 4.32 M 2.84 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 194,000.0 — 0.0 5,000.0 —
Income Tax 0.0 0.0 0.0 0.0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2.80 M 4.70 M 13.04 M 20.42 M 12.64 M
Total Liabilities 4.07 M 1.84 M 1.29 M 1.02 M 593,000.0
Shareholders' Equity -1.27 M 2.86 M 11.75 M 19.40 M 12.04 M
Total Debt — — — — —
Cash & Equivalents 600,000.0 — — 6.89 M 6.63 M
Current Assets 695,000.0 2.56 M 10.98 M 18.32 M 10.32 M
Current Liabilities 4.04 M 1.77 M 1.29 M 998,000.0 526,000.0